Infinimmune vs Kamada Pharmaceuticals
Infinimmune vs Kamada Pharmaceuticals, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and Kamada Pharmaceuticals on 50/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 50/100
Kamada Pharmaceuticals
- domain rating: 49/100 against 20/100
- funding raised: $150M against $75.0M
At a glance
| Measure | Infinimmune | Kamada Pharmaceuticals |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biopharma, Plasma-derived therapeutics, Orphan diseases, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Pharmaceuticals |
| Founded | 2017 | 1990 |
| Headquarters | Alameda, United States | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | Kamada Pharmaceuticals |
|---|---|---|
| Employees | 22 | Not published |
| Total funding | $75.0M | $150M |
| Latest round | Series A | Not published |
| LinkedIn followers | 4,055 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | Kamada Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 50/100 |
| Traction | 53/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 23/100 | 14/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 49/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | Kamada Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4 | Not detected |
Infinimmune vs Kamada Pharmaceuticals: common questions
Which is better, Infinimmune or Kamada Pharmaceuticals?
On our 0-100 score Infinimmune rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Infinimmune and Kamada Pharmaceuticals compare on the numbers?
Infinimmune leads on our overall score (60/100 against 50/100). Kamada Pharmaceuticals leads on domain rating (49/100 against 20/100), funding raised ($150M against $75.0M).
Read the full Infinimmune review and pricing or the Kamada Pharmaceuticals review and pricing. You can also browse other Infinimmune alternatives we track.